Experienced in Erectile Dysfunction (ED)

Florian Roghmann

Bochum, NW, DE 
Experienced in Erectile Dysfunction (ED)
Bochum, NW, DE 
OverviewLocationsClinical Research

Overview

Florian Roghmann practices in Bochum, Germany. Mr. Roghmann is rated as an Experienced expert by MediFind in the treatment of Erectile Dysfunction (ED). His top areas of expertise are Bladder Cancer, Urothelial Cancer, Prostate Cancer, Cystectomy, and Prostatectomy.

His clinical research consists of co-authoring 165 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Erectile Dysfunction (ED).

Gender
Male

Locations

Bochum, NW, Germany
Other Locations
Herne, NW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Randomised Controlled Multicentre Study of Albumin Replacement Therapy in Septic Shock
Randomised Controlled Multicentre Study of Albumin Replacement Therapy in Septic Shock
Enrollment Status: Terminated
Publish Date: October 28, 2024
Intervention Type: Drug
Study Drugs: Albutein, Plasbumin
Study Phase: Phase 3
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects With Invasive Urothelial Carcinoma With Susceptible FGFR3 Genetic Alterations (PROOF 302)
Enrollment Status: Terminated
Publish Date: March 13, 2024
Intervention Type: Drug
Study Drug: Infigratinib
Study Phase: Phase 3
A Phase I/II Open Label Clinical Trial Assessing Safety and Efficacy of Intravesical Instillation of VPM1002BC in Patients With Recurrent Non-muscle Invasive Bladder Cancer After Standard BCG Therapy
A Phase I/II Open Label Clinical Trial Assessing Safety and Efficacy of Intravesical Instillation of VPM1002BC in Patients With Recurrent Non-muscle Invasive Bladder Cancer After Standard BCG Therapy
Enrollment Status: Completed
Publish Date: April 13, 2023
Intervention Type: Drug
Study Drug: VPM1002BC
Study Phase: Phase 1/Phase 2
Impact of Preoperative Midazolam on Outcome of Elderly Patients: a Multicentre Randomised Controlled Trial
Impact of Preoperative Midazolam on Outcome of Elderly Patients: a Multicentre Randomised Controlled Trial
Enrollment Status: Completed
Publish Date: November 18, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 3 Less Clinical Trials

165 Total Publications

The utility of preoperative diagnostics in patients undergoing radical nephroureterectomy for suspected upper tract urothelial carcinoma: Can we justify treatment without prior histologic confirmation?
The utility of preoperative diagnostics in patients undergoing radical nephroureterectomy for suspected upper tract urothelial carcinoma: Can we justify treatment without prior histologic confirmation?
Journal: Surgical oncology
Published: August 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Roghmann's expertise for a condition
ConditionClose
View All 17 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile